The expression of the anti-apoptotic protein Bcl-2 was also significantly decreased in a dose-dependent manner (Figure 2C, p < 0.05); its expression was significantly lower in hesperetin-treated leukemia cells than in control cells. Here, BCL2 is linked to leukemia.